US Foods Holding Corp. delivered a quarter strong enough to put the Street on its heels — six analysts lifted price targets on the same morning, and the stock added 8.3% on August 6 before extending to close at $108.88 by Friday, up 8.2% on the week.
The analyst reaction was unusually unified. UBS, Citigroup, Wells Fargo, Guggenheim, BTIG, and TD Cowen all raised targets within hours of the print — moves ranging from $119 to $127, all while holding Buy or Overweight ratings. That kind of synchronized conviction is rare. The lone holdout tone came from Morgan Stanley, which kept an Equal-Weight and nudged its target only to $103 in mid-July — well below where the stock now trades. The mean Street target sits at $110.81, barely above the current price, meaning the consensus is already scrambling to catch up with the tape. UBS's new $127 target represents the high-end case, implying roughly 17% from Friday's close.
Options traders flipped hard toward calls after the number. The put/call ratio dropped to 0.40 on August 7 — more than 2.7 standard deviations below its 20-day average of 0.83. That's one of the most aggressively call-skewed readings in the past year, with the 52-week low on the PCR sitting at 0.29. The complete reversal from the hedged posture our August 3 note described — when the PCR had recently peaked near 1.38 — illustrates just how cleanly the earnings catalyst resolved the uncertainty.
Short sellers have continued their orderly retreat. Short interest fell a further 5.7% across the week to roughly 4.5% of the free float, down from around 12.8 million shares as recently as mid-July. That's a roughly 21% decline in short positions over the past month. The borrow market remains entirely frictionless: availability runs at over 1,000%, meaning there are about ten shares available to lend for every one currently borrowed, and cost to borrow is near 0.45% — close to its lowest level in months. The ORTEX short score has drifted down to 41.2, continuing the trend that began when the covering started in earnest. This is not a short squeeze story; it's a story of rational covering as the bull thesis firms up.
One institutional ownership detail is worth flagging. Wellington Management disclosed adding over 7.2 million shares in the quarter ending June 30, lifting its stake to 10.4% of the company — the largest disclosed institutional position on the register. T. Rowe Price added 5.4 million shares in the same period. Taken together, those two moves represent meaningful conviction from large active managers at prices well below where the stock now trades, underscoring how the institutional base was building before the print confirmed the operating outlook.
The bull case rests on margin expansion through self-help initiatives, technology investment, and a mix shift toward higher-margin independent restaurant and healthcare accounts. The bear case centers on those same customer segments — independent restaurants and hospitality face real pricing pressure, and any deterioration in those end markets would test the margin story directly. With no next earnings date yet set and the mean price target likely to move higher as remaining analysts update their models, the immediate focus shifts to whether the Street consensus can close the gap to the UBS and Citigroup high-end targets — or whether peer PFGC, flat on the week at +0.4%, offers a read on sector-level demand trends that complicates the re-rating thesis.
See the live data behind this article on ORTEX.
Open USFD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
